Scarica l'app Stockscreener
5.63
1.75%
-0.10
Dopo l'orario di chiusura:
5.63
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bausch Health Companies Inc Borsa (BHC) Ultime notizie
Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan
Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan
Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan
Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com UK
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia
Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan
Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media
Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Bausch Health Marks Arestin Milestone And Highlights Niche Dental Opportunity - Sahm
Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm
Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm
Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan
Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan
Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan
Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan
Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance
BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat
Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Bausch Health (NYSE: BHC) CEO granted 815K RSUs, 116K shares withheld for tax - Stock Titan
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Trading Recap: Is Bausch Health Companies Inc stock a value trapJuly 2025 Gainers & Free Community Consensus Stock Picks - baoquankhu1.vn
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PR Newswire
New anti-aging laser lets Canadian clinics target wrinkles, spots, pores - Stock Titan
Bausch Health Weighs China Aesthetics Push Against ARESTIN Milestone And Debt - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? - sharewise.com
Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), Bausch Health Companies (BHC) and Insulet (PODD) - The Globe and Mail
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Can Bausch Health Companies Inc expand into new markets2025 Trade Ideas & Weekly Sector Rotation Insights - baoquankhu1.vn
Bausch Health revenue by segment 2021-2024 - Statista
Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO) - Seeking Alpha
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Finviz
Bausch Health Cos (NYSE:BHC) Shares Gap DownTime to Sell? - MarketBeat
How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC) - Seeking Alpha
Bausch Health Companies Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - Yahoo Finance
Will Bausch Health Companies Inc announce a stock splitQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Bausch Health Companies Inc (BHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China - MSN
A Look At Bausch Health Companies (BHC) Valuation After Mixed Quarterly Results And China Expansion - Sahm
Bausch Health (BHC) Q4 2025 Earnings Transcript - The Globe and Mail
Bausch Health Cos Q4 Earnings Call Highlights - Yahoo Finance
Bausch Health (BHC) Q4 Earnings Lag Estimates - Yahoo Finance
Here's What Key Metrics Tell Us About Bausch (BHC) Q4 Earnings - Nasdaq
Bausch: Q4 Earnings Snapshot - kens5.com
Bausch Health Cos (NYSE:BHC) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Earnings Flash (BHC) Bausch Health Posts Q4 Loss $0.30 per Share, vs. FactSet Est of $0.58 EPS - marketscreener.com
Bausch Health shares fall after significant Q4 earnings miss By Investing.com - Investing.com South Africa
Bausch Health shares fall after significant Q4 earnings miss - Investing.com
Bausch Health earnings missed by $1.51, revenue topped estimates - Investing.com
Bausch Health Down 8.6% After Hours as Q4 Adjusted Earnings Narrow, But Revenue up - 富途牛牛
Bausch Health Companies Posts Q4 Loss - Nasdaq
Bausch Health Companies Q4 Earnings Report: What Investors Need to Know - Benzinga
0.21%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):